Pancreatic Cancer

被引：2312

作者：

Hidalgo, Manuel ^{[1
,2
,3
]}

机构：

[1] Ctr Nacl Invest Oncol, Madrid, Spain

[2] Hosp Madrid, Madrid, Spain

[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2010年 / 362卷 / 17期

关键词：

PHASE-III TRIAL; RANDOMIZED CONTROLLED-TRIAL; DUCTAL ADENOCARCINOMA; CURATIVE-INTENT; TUMOR-GROWTH; RISK-FACTORS; ADJUVANT CHEMOTHERAPY; PLUS CAPECITABINE; CLINICAL BENEFIT; STELLATE CELLS;

D O I：

10.1056/NEJMra0901557

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer remain unknown. This review article summarizes recent progress in the understanding and management of pancreatic cancer. Copyright © 2010 Massachusetts Medical Society.

引用

页码：1605 / 1617

页数：13

共 89 条

[1] Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse [J].

Bardeesy, N ;

Aguirre, AJ ;

Chu, GC ;

Cheng, KH ;

Lopez, LV ;

Hezel, AF ;

Feng, B ;

Brennan, C ;

Weissleder, R ;

Mahmood, U ;

Hanahan, D ;

Redston, MS ;

Chin, L ;

DePinho, RA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (15) :5947-5952

[2] Risk Factors for Pancreatic Cancer Mortality: Extended Follow-up of the Original Whitehall Study [J].

Batty, G. David ;

Kivimaki, Mika ;

Morrison, David ;

Huxley, Rachel ;

Smith, George Davey ;

Clarke, Robert ;

Marmot, Michael G. ;

Shipley, Martin J. .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (02) :673-675

[3] Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704 [J].

Berger, Adam C. ;

Garcia, Miguel, Jr. ;

Hoffman, John P. ;

Regine, William F. ;

Abrams, Ross A. ;

Safran, Howard ;

Konski, Andre ;

Benson, Alan B., III ;

MacDonald, John ;

Willett, Christopher G. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (36) :5918-5922

[4] Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone:: A randomized multicenter phase III clinical trial -: SAKK 44/00-CECOG/PAN.1.3.001 [J].

Bernhard, Juerg ;

Dietrich, Daniel ;

Scheithauer, Werner ;

Gerber, Daniela ;

Bodoky, Gyo Rgy ;

Ruhstaller, Thomas ;

Glimelius, Bengt ;

Bajetta, Emilio ;

Schueller, Johannes ;

Saletti, Piercarlo ;

Bauer, Jean ;

Figer, Arie ;

Pestalozzi, Bernhard C. ;

Hne, Claus-Henning Ko ;

Mingrone, Walter ;

Stemmer, Salomon M. ;

Tamas, Karin ;

Kornek, Gabriela V. ;

Koeberle, Dieter ;

Herrmann, Richard .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) :3695-3701

[5] Validation of the 6th Edition AJCC Pancreatic Cancer Staging System - Report from the National Cancer Database [J].

Bilimoria, Karl Y. ;

Bentrem, David J. ;

Ko, Clifford Y. ;

Ritchey, Jamie ;

Stewart, Andrew K. ;

Winchester, David P. ;

Talamonti, Mark S. .

CANCER, 2007, 110 (04) :738-744

[6] Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].

Burris, HA ;

Moore, MJ ;

Andersen, J ;

Green, MR ;

Rothenberg, ML ;

Madiano, MR ;

Cripps, MC ;

Portenoy, RK ;

Storniolo, AM ;

Tarassoff, P ;

Nelson, R ;

Dorr, FA ;

Stephens, CD ;

VanHoff, DD .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413

[7] Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer.: Definitive results of the 2000-01 FFCD/SFRO study [J].

Chauffert, B. ;

Mornex, F. ;

Bonnetain, F. ;

Rougier, P. ;

Mariette, C. ;

Bouche, O. ;

Bosset, J. F. ;

Aparicio, T. ;

Mineur, L. ;

Azzedine, A. ;

Hammel, P. ;

Butel, J. ;

Stremsdoerfer, N. ;

Maingon, P. ;

Bedenne, L. .

ANNALS OF ONCOLOGY, 2008, 19 (09) :1592-1599

[8] Stromal biology of pancreatic cancer [J].

Chu, Gerald C. ;

Kimmelman, Alec C. ;

Hezel, Aram F. ;

DePinho, Ronald A. .

JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 101 (04) :887-907

[9] In vitro and In vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 Kinase [J].

Chung, Eun Joo ;

Brown, Aaron P. ;

Asano, Hiroaki ;

Mandler, Mariana ;

Burgan, William E. ;

Carter, Donna ;

Camphausen, Kevin ;

Citrin, Deborah .

CLINICAL CANCER RESEARCH, 2009, 15 (09) :3050-3057

[10] The prevalence of BRCA2 mutations in familial pancreatic cancer [J].

Couch, Fergus J. ;

Johnson, Michele R. ;

Rabe, Kari G. ;

Brune, Kieran ;

de Andrade, Mariza ;

Goggins, Michael ;

Rothenmund, Heidi ;

Gallinger, Steven ;

Klein, Alison ;

Petersen, Gloria M. ;

Hruban, Ralph H. .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (02) :342-346

← 1 2 3 4 5 6 7 8 9 →